Login / Signup
Use of the Patient Benefit Index to monitor treatment of chronic spontaneous urticaria with omalizumab.
Astrid C Chodziuk
Misbah Noshela Ghazanfar
Simon Francis Thomsen
Published in:
Dermatologic therapy (2019)
Keyphrases
</>
case report
combination therapy
drug induced